BIT
IDXG

BlackRock Institutional Trust’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

BlackRock Institutional Trust’s Portfolio IDXG Stock Details IDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$353K Buy
8,012
+5,774
+258% +$184K ﹤0.01% 3511
2016
Q3 		$36K Hold
2,238
– – ﹤0.01% 3774
2016
Q2 		$74K Hold
2,238
– – ﹤0.01% 3740
2016
Q1 		$63K Hold
2,238
– – ﹤0.01% 3771
2015
Q4 		$104K Hold
2,238
– – ﹤0.01% 3744
2015
Q3 		$401K Hold
2,238
– – ﹤0.01% 3541
2015
Q2 		$320K Hold
2,238
– – ﹤0.01% 3573
2015
Q1 		$302K Buy
2,238
+56
+3% +$9.16K ﹤0.01% 3585
2014
Q4 		$390K Sell
2,182
-120
-5% -$21.4K ﹤0.01% 3539
2014
Q3 		$553K Hold
2,302
– – ﹤0.01% 3465
2014
Q2 		$1.01M Hold
2,302
– – ﹤0.01% 3430
2014
Q1 		$1.05M Hold
2,302
– – ﹤0.01% 3401
2013
Q4 		$1.11M Hold
2,302
– – ﹤0.01% 3368
2013
Q3 		$1.11M Buy
2,302
+14
+0.6% +$6.71K ﹤0.01% 3331
2013
Q2 		$1.08M Buy
+2,288
New +$1.04M ﹤0.01% 3316

Other funds holding IDXG

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

BlackRock Institutional Trust's IDXG Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Interpace Biosciences, Inc. Common Stock (IDXG) stake by 258% in Q4 2016, buying an estimated $184K and bringing the position to 8,012 shares worth $353K. The position accounts for ﹤0.01% of the portfolio, ranked #3511.

BlackRock Institutional Trust first reported a position in IDXG in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.11M in Q3 2013. 14 funds tracked by Wall St. Rank hold IDXG as of Q4 2016.

  • BlackRock Institutional Trust held 8,012 shares of Interpace Biosciences, Inc. Common Stock worth $353K as of Q4 2016.
  • BlackRock Institutional Trust bought 5,774 Interpace Biosciences, Inc. Common Stock shares in Q4 2016, an estimated $184K.
  • Interpace Biosciences, Inc. Common Stock made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3511 holding.
  • BlackRock Institutional Trust first reported a position in Interpace Biosciences, Inc. Common Stock in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Interpace Biosciences, Inc. Common Stock position peaked at $1.11M in Q3 2013.
  • 14 funds tracked by Wall St. Rank held Interpace Biosciences, Inc. Common Stock as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.